Development and desensitization therapy of high-response factor VIII inhibitors with severe allergic reaction in a moderate hemophilia A patient

Neutralizing antibodies (inhibitors) against factor VIII/IX (FVIII/FIX) poses a serious and challenging complication in the hemophilia treatment. Allergic reaction is more common in hemophilia B and always companion with FIX inhibitors, but it is rare in hemophilia A (HA). So far only few cases demo...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Guoqing, Chen, Zhenping, Wu, Wenman, Wu, Runhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917874/
https://www.ncbi.nlm.nih.gov/pubmed/33626954
http://dx.doi.org/10.1177/2058738420980259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7917874/
https://www.ncbi.nlm.nih.gov/pubmed/33626954
http://dx.doi.org/10.1177/2058738420980259

Ejemplares similares